Burnett AK - Search Results

1

Distinct poor prognostic subgroups of acute myeloid leukaemia, FLT3-ITD and P-glycoprotein-positive, have contrasting levels of FOXO1.

Seedhouse CH, Mills KI, Ahluwalia S, Grundy M, Shang S, Burnett AK, Russell NH, Pallis M. Seedhouse CH, et al. Among authors: burnett ak. Leuk Res. 2014 Jan;38(1):131-7. doi: 10.1016/j.leukres.2013.10.030. Epub 2013 Nov 8. Leuk Res. 2014. PMID: 24268349

2

Changing p53 mutations with the evolution of chronic myeloid leukaemia from the chronic phase to blast crisis.

Guinn BA, Smith M, Padua RA, Burnett A, Mills K. Guinn BA, et al. Leuk Res. 1995 Aug;19(8):519-25. doi: 10.1016/0145-2126(95)00024-i. Leuk Res. 1995. PMID: 7658697

3

In vitro drug resistance in acute myeloid and chronic B-lymphocytic leukaemic blasts and in normal blood and marrow populations.

Baines P, Limaye M, Hoy T, Padua RA, Whittaker J, al-Sabah A, Burnett A. Baines P, et al. Leuk Res. 1994 Sep;18(9):683-91. doi: 10.1016/0145-2126(94)90068-x. Leuk Res. 1994. PMID: 7934144

4

Allelic loss of the FMS gene in acute myeloid leukaemia.

McGlynn H, Kapelko K, Baker A, Burnett A, Padua RA. McGlynn H, et al. Leuk Res. 1997 Oct;21(10):919-23. doi: 10.1016/s0145-2126(97)00024-6. Leuk Res. 1997. PMID: 9403002

5

Increased circulating normal and BCR-ABL+Ve progenitor numbers in Philadelphia chromosome-positive acute myeloid leukaemia.

Baines P, Austin S, Fisher J, Owen-Jones E, Lee-Jones L, Throp D, Mckinley M, Hoy T, Mills K, Thompson P, Burnett A. Baines P, et al. Leuk Res. 2002 Nov;26(11):997-1005. doi: 10.1016/s0145-2126(02)00049-8. Leuk Res. 2002. PMID: 12363468

6

Reproducible measurements of AML blast p-glycoprotein function in 2 center analyses.

Pallis M, Fisher J, Truran L, Grundy M, Russell N, Burnett A. Pallis M, et al. Blood. 2005 Feb 1;105(3):1367-8. doi: 10.1182/blood-2004-08-3303. Blood. 2005. PMID: 15659619 Free article. No abstract available.

7

Microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia.

Guinn BA, Gilkes AF, Woodward E, Westwood NB, Mufti GJ, Linch D, Burnett AK, Mills KI. Guinn BA, et al. Among authors: burnett ak. Biochem Biophys Res Commun. 2005 Aug 5;333(3):703-13. doi: 10.1016/j.bbrc.2005.05.161. Biochem Biophys Res Commun. 2005. PMID: 15963951

8

Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia.

Gale RE, Hills R, Pizzey AR, Kottaridis PD, Swirsky D, Gilkes AF, Nugent E, Mills KI, Wheatley K, Solomon E, Burnett AK, Linch DC, Grimwade D; NCRI Adult Leukaemia Working Party. Gale RE, et al. Among authors: burnett ak. Blood. 2005 Dec 1;106(12):3768-76. doi: 10.1182/blood-2005-04-1746. Epub 2005 Aug 16. Blood. 2005. PMID: 16105978 Free article.

9

The tumour antigens RAGE-1 and MGEA6 are expressed more frequently in the less lineage restricted subgroups of presentation acute myeloid leukaemia.

Guinn BA, Gilkes AF, Mufti GJ, Burnett AK, Mills KI. Guinn BA, et al. Among authors: burnett ak. Br J Haematol. 2006 Jul;134(2):238-9. doi: 10.1111/j.1365-2141.2006.06135.x. Br J Haematol. 2006. PMID: 16846483 Free article. No abstract available.

10

FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia.

Mead AJ, Linch DC, Hills RK, Wheatley K, Burnett AK, Gale RE. Mead AJ, et al. Among authors: burnett ak. Blood. 2007 Aug 15;110(4):1262-70. doi: 10.1182/blood-2006-04-015826. Epub 2007 Apr 24. Blood. 2007. PMID: 17456725 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters